Sources have told the Wall Street Journal the fund is set to raise less than half the $108bn in MOUs SoftBank received, with the corporate supplying most of that capital itself.

The deep tech-focused commercialisation vehicle currently has 10 portfolio companies having smashed its original $54.8m fundraising target.

Cornes, 3M Ventures and Repsol Energy Ventures contributed to a round that increased the in-mold structural electronics provider's total funding to more than $59m.

Biocodex returned for a $19.8m round that boosted microbiome drug developer MaaT Pharma's overall funding to more than $33m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The tissue analysis technology developer has now raised more than $37m, having received $23.6m in a first tranche of its series C round that was led by PHC Holdings.

Dell Technologies Capital and Qualcomm Ventures both invested in a $21.5m round that will fund growth of FloLive's internet-of-things managment platform.

EPFL-founded tissue analysis technology developer Lunaphore has now raised $37.3m in all after a series C round led by medical products firm PHC Holdings.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.